Principal Investigator: Raj Makkar, MD

Co-Investigators: P.K. Shah, MD; Stephen Lim, MD; Michael Lee, MD; Michael Lill, MD

IRB Approval Number: 4441

Condition Disease: Decreased heart muscle function following a heart attack

Description: Cardiologists at Cedars-Sinai Heart Institute are currently conducting a clinical trial into the use of a patient's own bone-marrow-derived stem cells as a potential therapy in heart muscle repair.

Patients who have suffered a heart attack and undergone angioplasty and stent placement within the past 10 days may be eligible to participate in this innovative new study. To qualify, patients must have evidence of decreased heart muscle function.

Stem cell treatment is a two-step, nonsurgical procedure. Qualified participants are given a local anesthetic, and cells are removed from the bone marrow. Stem cells are then isolated and injected into the coronary artery responsible for the heart attack.

Participants in this study will have cardiac MRI testing and other noninvasive evaluations and lab work at scheduled intervals for up to one year.

To download a flyer that can be distributed to patients who are potential candidates,
click here.

For more information, please contact: